5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.07▼ | 8.03▼ | 8.03▼ | 8.08▼ | 8.31▼ |
MA10 | 8.36▼ | 8.47▼ | 8.47▼ | 8.59▼ | 7.33▲ |
MA20 | 8.44▼ | 8.06▼ | 7.96▼ | 8.50▼ | 7.81▲ |
MA50 | 7.33▲ | 7.07▲ | 7.08▲ | 7.42▲ | 9.31▼ |
MA100 | 7.00▲ | 6.82▲ | 6.77▲ | 7.82▲ | 13.01▼ |
MA200 | 6.66▲ | 7.02▲ | 7.03▲ | 8.92▼ | 34.78▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.153▼ | -0.099▼ | -0.086▼ | -0.147▼ | 0.280▲ |
RSI | 48.934▼ | 52.114▲ | 52.378▲ | 48.831▼ | 48.199▼ |
STOCH | 12.768▼ | 20.171 | 20.755 | 31.123 | 69.112 |
WILL %R | -91.582▼ | -91.582▼ | -91.582▼ | -76.471▼ | -37.753 |
CCI | -78.731 | -81.249 | -76.225 | -95.230 | 45.535 |
Friday, June 13, 2025 04:30 AM
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/07/25 | 7.8742 | 8.3709 | 7.80 | 8.02 | 14,696 |
16/07/25 | 7.62 | 8.38 | 7.62 | 8.2043 | 2,144 |
15/07/25 | 7.95 | 7.95 | 7.95 | 7.95 | 625 |
14/07/25 | 8.30 | 8.30 | 7.6505 | 8.085 | 10,065 |
11/07/25 | 8.90 | 8.90 | 8.1654 | 8.1654 | 3,032 |
10/07/25 | 9.15 | 9.15 | 8.24 | 9.0999 | 5,717 |
09/07/25 | 9.15 | 9.15 | 9.15 | 9.15 | 478 |
08/07/25 | 9.00 | 9.265 | 8.7622 | 9.03 | 4,662 |
07/07/25 | 9.015 | 9.15 | 8.80 | 9.15 | 3,783 |
03/07/25 | 9.00 | 9.07 | 9.00 | 9.03 | 5,809 |
|
|
||||
|
|
||||
|
|